BMJ Best Practice

参考文献

关键文献

Smouha EE, Yoo M, Mohr K, et al. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope. 2005;115:450-454.

Lin VY, Stewart C, Grebenyuk J, et al. Unilateral acoustic neuromas: long-term hearing results in patients managed with fractionated stereotactic radiotherapy, hearing preservation surgery, and expectantly. Laryngoscope. 2005;115:292-296.

Pollock BE. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery. 2006;58:241-248.

Darrouzet V, Martel J, Enee V, et al. Vestibular schwannoma surgery outcomes: our multidisciplinary experience in 400 cases over 17 years. Laryngoscope. 2004;114:681-688.

Roland JT Jr, Fishman AJ, Golfinos JG, et al. Cranial nerve preservation in surgery for large acoustic neuromas. Skull Base. 2004;14:85-91.

参考文章

1.  Tos M, Charabi S, Thomsen J. Clinical experience with vestibular schwannomas: epidemiology, symptomatology, diagnosis, and surgical results. Eur Arch Otorhinolaryngol. 1998;255:1-6.

2.  Jones KD. Summary: vestibular schwannoma (acoustic neuroma) consensus development conference. Neurosurgery. 1993;32:878-879.

3.  Smouha EE, Yoo M, Mohr K, et al. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope. 2005;115:450-454.

4.  Hoistad DL, Melnik G, Mamikoglu B, et al. Update on conservative management of acoustic neuroma. Otol Neurotol. 2001;22:682-685.

5.  Beenstock M. Predicting the stability and growth of acoustic neuromas. Otol Neurotol. 2002;23:542-549.

6.  Deen HG, Ebersold MJ, Harner SG, et al. Conservative management of acoustic neuroma: an outcome study. Neurosurgery. 1996;39:260-266.

7.  Harner SG, Laws ER Jr. Clinical findings in patients with acoustic neuromas. Mayo Clin Proc. 1983;58:721-728.

8.  Selesnick SH, Johnson G. Radiologic surveillance of acoustic neuromas. Am J Otol. 1998;19:846-849.

9.  Fucci MJ, Buchman CA, Brackmann DE, et al. Acoustic tumor growth: implications for treatment choices. Am J Otol. 1999;20:495-499.

10.  Fortnum H, O'Neill C, Taylor R, et al. The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history. Health Technol Assess. 2009;13:1-154.

11.  Arthurs BJ, Fairbanks RK, Demakas JJ, et al. A review of treatment modalities for vestibular schwannoma. Neurosurg Rev. 2011;34:265-277.

12.  Nikolopoulos TP, Fortnum H, O'Donoghue G, et al. Acoustic neuroma growth: a systematic review of the evidence. Otol Neurotol. 2010;31:478-485.

13.  Maniakas A, Saliba I. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up. Otol Neurotol. 2012;33:230-238.

14.  Lin VY, Stewart C, Grebenyuk J, et al. Unilateral acoustic neuromas: long-term hearing results in patients managed with fractionated stereotactic radiotherapy, hearing preservation surgery, and expectantly. Laryngoscope. 2005;115:292-296.

15.  Pollock BE. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery. 2006;58:241-248.

16.  Prasad D, Steiner M, Steiner L. Gamma surgery for vestibular schwannoma. J Neurosug. 2000;92:745-759.

17.  Pollock BE, Lunsford LD, Noren G. Vestibular schwannoma management in the next century: a radiosurgical perspective. Neurosurgery. 1998;43:475-483.

18.  Barker FG II, Carter BS, Ojemann RG, et al. Surgical excision of acoustic neuroma: patient outcome and provider caseload. Laryngoscope. 2003;113:1332-1343.

19.  Darrouzet V, Martel J, Enee V, et al. Vestibular schwannoma surgery outcomes: our multidisciplinary experience in 400 cases over 17 years. Laryngoscope. 2004;114:681-688.

20.  Ciric I, Zhao JC, Rosenblatt S, et al. Suboccipital retrosigmoid approach for removal of vestibular schwannomas: facial nerve function and hearing preservation. Neurosurgery. 2005;56:560-570.

21.  Akagami R, Dong CC, Westerberg BD. Localized transcranial electric motor evoked potentials for monitoring cranial nerves in cranial base surgery. Neurosurgery. 2005;57(suppl 1):78-85.

22.  Dong CC, MacDonald DB, Akagami R, et al. Intraoperative facial motor evoked potential monitoring with transcranial electrical stimulation during skull base surgery. Clin Neurophysiol. 2005;116:588-596.

23.  Roland JT Jr, Fishman AJ, Golfinos JG, et al. Cranial nerve preservation in surgery for large acoustic neuromas. Skull Base. 2004;14:85-91.

24.  Ansari SF, Terry C, Cohen-Gadol AA. Surgery for vestibular schwannomas: a systematic review of complications by approach. Neurosurg Focus. 2012;33:E14.

25.  Friedman RA, Brackmann DE, Hitselberger WE, et al. Surgical salvage after failed irradiation for vestibular schwannoma. Laryngoscope. 2005;115:1827-1832.

26.  Ryzenman JM, Pensak ML, Tew JM Jr. Headache: a quality of life analysis in a cohort of 1,657 patients undergoing acoustic neuroma surgery, results from the acoustic neuroma association. Laryngoscope. 2005;115:703-711.

27.  Di Lella F, Merkus P, Di Trapani G, et al. Vestibular schwannoma in the only hearing ear: role of cochlear implants. Ann Otol Rhinol Laryngol. 2013;122:91-99.

28.  Plotkin SR, Halpin C, Blakeley JO, et al. Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol. 2009;93:61-77.

29.  Plotkin SR, Halpin C, McKenna MJ, et al. Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients. Otol Neurotol. 2010;31:1135-1143.

30.  Plotkin SR, Merker VL, Halpin C, et al. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol. 2012;33:1046-1052.

31.  Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med. 2009;361:358-367.

32.  Pannullo SC, Fraser JF, Moliterno J, et al. Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease. J Neurooncol. 2011;103:1-17.

33.  Schmerber S, Palombi O, Boubagra K, et al. Long-term control of vestibular schwannoma after a translabyrinthine complete removal. Neurosurgery. 2005;57:693-698.

34.  Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery. 1997;40:11-21.

35.  Pollock BE, Lunsford LD, Kondziolka D, et al. Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery. 1995;36:215-224.

36.  Akagami R, Di Maio S. Prospective comparison of quality of life before and after observation, radiation, or surgery for vestibular schwannomas. J Neurosurg. 2009;111:855-862.

37.  Sughrue ME, Yang I, Aranda D, et al. Hearing preservation rates after microsurgical resection of vestibular schwannoma. J Clin Neurosci. 2010;17:1126-1129.

38.  Yong RL, Westerberg BD, Dong C, et al. Length of tumor-cochlear nerve contact and hearing outcome after surgery for vestibular schwannoma. J Neurosurg. 2008;108:105-110.

39.  Passier L, Doherty D, Smith J, et al. Vestibular rehabilitation following the removal of an acoustic neuroma: a systematic review of randomized trials. Head Neck Oncol. 2012;4:59.

40.  McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015;(1):CD005397.

41.  Yang I, Aranda D, Han SJ, et al. Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci. 2009;16:742-747.

42.  Yang I, Sughrue ME, Han SJ, et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol. 2009;93:41-48.

43.  Muracciole X, Regis J. Radiosurgery and carcinogenesis risk. Prog Neurol Surg. 2008;21:207-213.

44.  Ryzenman JM, Pensak ML, Tew JM Jr. Facial paralysis and surgical rehabilitation: a quality of life analysis in a cohort of 1,595 patients after acoustic neuroma surgery. Otol Neurotol. 2005;26:516-521.

45.  Hastan D, Vandenbroucke JP, van der Mey AG. A meta-analysis of surgical treatment for vestibular schwannoma: is hospital volume related to preservation of facial function? Otol Neurotol. 2009;30:975-980.

使用此内容应接受我们的免责声明